3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
43
Lymphoma, Follicular
22
Lymphoma, Non-Hodgkin
17
Lymphoma, Mantle-Cell
16
Lymphoma, Large B-Cell, Diffuse
15
Lymphoma
14
Lymphoma, B-Cell, Marginal Zone
12
Lymphoma, B-Cell
8
Recurrence
7
Neoplasms
6
Burkitt Lymphoma
5
Leukemia, B-Cell
4
Neoplasm, Residual
3
Leukemia, Hairy Cell
2
Leukemia
2
Dendritic Cell Sarcoma, Interdigitating
2
Waldenstrom Macroglobulinemia
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Prostatic Neoplasms
1
Part1: Advanced B-cell Malignancies
1
Ovarian Neoplasms
1
Mesothelioma
1
Melanoma
1
Mature B-cell Malignancies
1
Mature B-Cell Malignancies
1
Lymphoproliferative Disorders
1
Lymphatic Diseases
1
Leukemia, Prolymphocytic
1
Interventions
Fulvestrant
5
serabelisib
2
sapanisertib
2
ribociclib
2
palbociclib
2
Paclitaxel
2
Letrozole
2
Irinotecan
2
Gemcitabine
2
Carboplatin
2
Alpelisib
2
venetoclax
1
tivozanib
1
tipifarnib
1
sotorasib
1
pembrolizumab
1
olaparib
1
niraparib
1
lorlatinib
1
liposomal doxorubicin
1
inavolisib
1
exemestane
1
encorafenib
1
ceralasertib
1
cemiplimab
1
capivasertib
1
binimetinib
1
abemaciclib
1
Taxes
1
Tamoxifen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hereditary Sensory and Autonomic Neuropathies
×
obinutuzumab
×
1 year
×
Clear all
No trials found.